EXI3:XETRA:XETRA-iShares Dow Jones Industrial Average UCITS ETF (DE) (EUR)

ETF | Others |

Last Closing

USD 367.85

Change

+1.40 (+0.38)%

Market Cap

USD 0.30B

Volume

242.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-08-28 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

+1.17 (+2.33%)

USD 484.40B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

+0.38 (+2.35%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

+0.62 (+2.37%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

+0.63 (+2.30%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

+0.66 (+2.76%)

USD 157.79B
8R80:XETRA Amundi Index Solutions - Amund..

+3.78 (+2.75%)

USD 98.29B
JARI:XETRA Amundi Index Solutions - Amund..

+0.79 (+1.74%)

USD 98.25B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

+1.15 (+2.31%)

USD 85.64B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

+6.54 (+1.22%)

USD 80.38B
FRCJ:XETRA UBS MSCI Japan Socially Respon..

+0.43 (+1.90%)

USD 79.79B

ETFs Containing EXI3:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 8.37% 58% F 60% D-
Dividend Return 0.59% 19% F 12% F
Total Return 8.95% 60% D- 61% D-
Trailing 12 Months  
Capital Gain 15.51% 65% D 66% D+
Dividend Return 0.63% 15% F 10% F
Total Return 16.14% 66% D+ 67% D+
Trailing 5 Years  
Capital Gain 53.85% 70% C- 71% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 53.85% 69% C- 68% D+
Average Annual (5 Year Horizon)  
Capital Gain 10.55% 74% C 72% C
Dividend Return 10.89% 75% C 71% C-
Total Return 0.34% 55% F 21% F
Risk Return Profile  
Volatility (Standard Deviation) 11.65% 53% F 62% D
Risk Adjusted Return 93.49% 94% A 94% A
Market Capitalization 0.30B 54% F 48% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike